Sacituzumab Govitecan-hziy in Refractory Metastatic Triple-Negative Breast Cancer

Bardia, A; Mayer, IA; Vahdat, LT; Tolaney, SM; Isakoff, SJ; Diamond, JR; O'Shaughnessy, J; Moroose, RL; Santin, AD; Abramson, VG; Shah, NC; Rugo, HS; Goldenberg, DM; Sweidan, AM; Iannone, R; Washkowitz, S; Sharkey, RM; Wegener, WA; Kalinsky, K

Bardia, A (reprint author), Harvard Med Sch, Massachusetts Gen Hosp, Canc Ctr, Lawrence House 304,10 N Grove St, Boston, MA 02114 USA.

NEW ENGLAND JOURNAL OF MEDICINE, 2019; 380 (8): 741

Abstract

BACKGROUND Standard chemotherapy is associated with low response rates and short progression-free survival among patients with pretreated metastatic t......

Full Text Link